JP Morgan Has Best Aftermarket Performance for Accelerated Deals
Korea Biomedical Review had an email interview with David Lau, Co-head of China Investment Banking and Co-head of Asia Healthcare Investment Banking at J.P. Morgan, for the second consecutive year to hear more about the conference and his prediction for the healthcare industry in 2024. ...
A critical piece of evidence against JPMorgan was that despite funneling loans to both Madoff and Levy, the bank “advised the rest of its Private Bank customers not to invest with Madoff,” according to Picard. On paper, according to...
实习收获: On-the-job experience You’ll gain an in-depth understanding of risk management, working across industries and responding to client requests. You’ll actively contribute to deals, such as M&A and financing transactions, and participate in all other aspects of client credit management. Tr...
By Pam Martens and Russ Martens: May 21, 2015 After more than 200 years of operation, yesterday JPMorgan Chase became an admitted felon. That action for
Something has been building at JPMorgan. For years, a common question in the industry has been: why isn’t the bank, for all its global strength, doing better in Asia? It has always been close to the top in Asian investment banking but rarely troubles Go
Besides Goldman Sachs, the Street’s other surviving behemoth is JPMorgan. Today it posted second-quarter earnings up a stunning 36 percent from the first quarter, to $2.7 billion. The resurgence of JPMorgan (JPM) and Goldman Sachs (GS) gives both banks more financial clout than any other ...
JPMorgan advised on more than $1 trillion in announced M&A in 2018, including important deals such as Takeda’s $82 billion acquisition of Shire, IBM’s $34 billion purchase of Red Hat and Walmart’s $16 billion acquisition of Flipkart, India’s largest online retailer. It participated in...
The JPMorgan health care conference hadn't even officially begun when the first big piece of news of the week hit: Irish drugmaker Shire said Sunday morning it's purchasing orphan-drug company NPS Pharmaceuticals for $5.2 billion.
JPMorgan Chase’s $1.7 Billion Depositary Shares Offering October 20, 2018October 13, 2018Ambrogio Visconti Tagged:megadeals Cravath represented the underwriters, led by J.P. Morgan Securities, in connection with the $1.7 billion offering of depositary shares representing preferred stock of JPMorgan ...